EVERJOY HEALTH(002162)2025-01-23 09:45Financial Performance Expectations - The company expects a net loss attributable to shareholders of between 135 million and 165 million yuan for the year 2024, compared to a profit of 50.06 million yuan in the same period last year[2]. - The projected operating revenue for 2024 is between 1.1 billion and 1.3 billion yuan, down from 1.278 billion yuan in the previous year[2]. - The basic earnings per share are expected to be a loss of between 0.15 yuan and 0.18 yuan, compared to earnings of 0.054 yuan per share last year[2]. Reasons for Expected Loss - The primary reason for the expected loss is intensified competition in the building ceramics industry, leading to a decrease in revenue from tile products despite an increase in sales volume[4]. - The company anticipates credit impairment losses due to lower-than-expected recovery of certain receivables, impacting overall financial performance[4]. - A goodwill impairment test was conducted on the company's subsidiary, which did not meet profit expectations, indicating potential impairment of assets[4]. Tax and Non-Recurring Items - The company has recognized a deferred tax asset reversal of approximately 40 million yuan based on cautious estimates of future taxable income[5]. - Non-recurring gains and losses are estimated to impact net profit by about 25 million yuan, primarily from the reversal of impairment provisions and government subsidies[5]. Business Operations and Cautionary Notes - The company has terminated its negative ion health materials business, leading to impairment losses on related production facilities and land[4]. - Investors are advised to exercise caution as the performance forecast is based on preliminary estimates and has not been audited by the accounting firm[6].